Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations-Reference-Cited by-同舟云学术

Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations

Published:2021-07 Issue: Volume:109 Page:110241
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Ma Lingyue,Xiang Qian,Zhao Nan,Hu Changqing,Fang Meng,Tan Yunlong,Chen Song,Wang Zining,Liu Pinglan,Sun Kaoxiang,Li Youxin,Wu Fuxi,Tian Hongjun,Fang Maosheng,Zhao Xia,Wang Gang,Cui Yimin

Funder

National Major Science and Technology Projects of China

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference40 articles.

1. CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment. Pharmacogenet;Almoguera;Genomics,2013

2. Polymorphisms in the ABC drug transporter gene MDR1;Brinkmann;Pharmacogenom. J.,2001

3. Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group;Caudle;Clin. Transl. Sci.,2020

4. Pharmacogenetic study on risperidone long-acting injection;Choong;J. Clin. Psychopharmacol.,2013

5. The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part II: pharmacological issues and further understanding;de Leon;Rev. Psiquiatr. Salud. Ment.,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia;Neurology and Therapy;2024-01-20

2. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review;Pharmacogenomics;2022-11